Measuring patient safety in ambulatory care: potential for identifying medical group drug-drug interaction rates using claims data.

Abstract

Potential DDI rates calculated from health-plan data have promise for measurement in patient medication safety. This readily available and inexpensive evaluation tool has potential for monitoring, improvement, and research purposes if further studies validate their relationship to actual adverse events.